<DOC>
	<DOCNO>NCT01528384</DOCNO>
	<brief_summary>This phase 1 study pegylated arginine deiminase ( ADI-PEG 20 ) pediatric patient deficient expression tumor argininosuccinate synthetase , fail prior treatment . The study hypothesis drug safe pediatric patient .</brief_summary>
	<brief_title>Ph 1 Study ADI PEG 20 Pediatric Subjects Who Are Argininosuccinate Synthetase ( ASS ) Deficient</brief_title>
	<detailed_description>This phase 1 study use classic 3 dose level 3 patient per dose level design . Once maximum tolerate dose reach , additional patient may enrol dose level .</detailed_description>
	<criteria>1 . Prior diagnosis fail current standard treatment ( ) , AEs associate prior systemic agent ( ) result discontinuance agent ( ) . 2 . Argininosuccinate synthetase deficient tumor . 3 . Measurable disease assess &gt; 5 % blast bone marrow aspirate patient leukemia use RECIST 1.1 criterion solid tumor . 4 . Age 4 ≤ 18 year . 5 . No prior systemic treatment tumor last 2 week solid tumor 1 week leukemia , except hydroxyurea use control high WBC . 6 . Fully recover prior surgery major surgery within 4 week initiate treatment . Surgery placement vascular access device acceptable . 7 . Female subject 10 year old male subject must ask use appropriate contraception male female duration study . 8 . No concurrent investigational study allow . 9 . For solid tumor subject : Absolute neutrophil count ( ANC ) &gt; 750/µL . 10 . For solid tumor subject : Platelets &gt; 50,000/µL . 11 . For solid tumor subject : Serum uric acid ≤ 8 mg/dL ( without medication control ) . 12 . Serum creatinine ≤ 1.5 x upper limit normal range , , serum creatinine &gt; 1.5 x upper limit normal range , creatinine clearance must ≥ 60 mL/min . 1 . Serious infection require treatment systemically administer antibiotic time study entrance . 2 . Pregnancy lactation . 3 . Expected noncompliance . 4 . Uncontrolled intercurrent illness . 5 . Subjects anticancer treatment prior enter study recover baseline ≤ Grade 1 AEs due agent administer . 6 . Subjects treat ADIPEG 20 previously . 7 . History seizure disorder relate underlying cancer . 8 . Known HIV positivity .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Arginine</keyword>
	<keyword>Arginine deiminase</keyword>
	<keyword>Argininosuccinate synthetase</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Failed treatment</keyword>
	<keyword>Pediatric patient</keyword>
</DOC>